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The development of emphysema is thought to be
due to an imbalance of proteases (especially
neutrophil elastase [NE]) and antiproteases with
loosening of the respiratory epithelium as an
early event. We investigated the effect of NE on
respiratory epithelial cell adherence in vitro, in
the presence of varying concentrations and com-
binations of native inhibitors, a-1-proteinase in-
hibitor (PI) and secretory leukoprotease inhibitor
(SLPI). SLPI was two to 12 times more effective
than PI at preventing the effects of NE, especially
when enzyme:inhibitor ratios were almost equiva-
lent. Even when the concentration of SLPI was
only 10% of the total (as in normal peripheral
lung secretions), it gave greater protection than
PI alone. This suggests that SLPI plays an impor-
tant role in controlling neutrophil elastase-
induced in ammation and tissue damage.
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Introduction
Historically neutrophil elastase (NE) has been
regarded as the primary mediator of tissue
damage which occurs during pulmonary em-
physema, notably by degradation of extracellu-
lar matrix.1 More recent evidence suggests that
NE activates certain metalloproteinases whilst
inactivating their inhibitors2,3 and that metallo-
proteinase levels are raised in emphysematous
patients4 suggesting that NE and metallopro-
teinases act in concert in the aetiology/pathol-
ogy of this disease. In addition, NE has been
shown to play a pro-inammatory role in
pulmonary inammation involving neutrophil
inux. For example, activation of complement
to C5a5 and stimulation of IL-8 synthesis and
secretion by airway epithelial cells6 would
amplify neutrophil inux, whilst its ability to
reduce airway epithelial cell ciliary beat fre-
quency and secretagogue activity7,8 would con-
tribute to reduced clearance during diseases
such as chronic bronchitis and cystic  brosis.
Thus NE activity is normally strictly regulated
by systemic and locally produced inhibitors.
SLPI (12 kD) is a reversible inhibitor of NE,
synthesized and secreted by non-ciliated airway
and bronchiolar secretory cells;9SLPI will inhibit
NE even when bound to a substrate.10 In
contrast, PI (52 kD) is the major serum-derived
inhibitor of NE and transudes into the intersti-
tium and airspaces of the lung. It complexes
with, and irreversibly inhibits, free NE10 as well
as dissociating and inactivating NE bound to
other, reversible, inhibitors e.g. SLPI,11 prior to
clearance of NE:PI complexes from the circula-
tion. Elan (12±14 kD) is synthesized by both
Clara-like and alveolar type II pneumocyte-like
cell lines;12 the mechanism of action of elan
has not been completely characterized. Analysis
of the antineutrophil elastase screen in human
bronchoalveolar lavage shows that although PI
forms a relatively high proportion of this
screen13 (except in PI deciency, which predis-
poses to the development of emphysema), the
other locally produced inhibitors are present at
levels that suggest they also play a signicant
role in controlling the action of NE in epithelial
lining uid.14 Like PI, SLPI and elan may also
vary in concentration between healthy indivi-
duals and according to the disease state of the
lung.13,15 Thus it seems likely that control of
extracellular NE could depend not only on the
relative levels and synchronized action of these
different inhibitors but also on the levels and
site of deposition of NE i.e. within the epithelial
lining uid or interstitium.
Induction of SLPI mRNA levels in primary
human airway epithelial cells,16 and retention of
SLPI activity by proteolysed SLPI fragments
following exposure to NE,17 suggests that in-
creased SLPI levels provide a sustained local
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anti-NE defence mechanism against excessive
pulmonary NE activity. In addition, aerosolized
rSLPI stimulates glutathione levels in sheep
epithelial lining uid18 and downregulates IL-8
levels in respiratory secretions from patients
with cystic  brosis,19 suggesting that SLPI has
an important anti-in ammatory role in the lung.
Previous investigations comparing the ability
of PI and SLPI to prevent neutrophil-mediated
proteolysis of brinogen20,21 and neutrophil-in-
duced detachment of human umbilical endothe-
lial cells22 have shown that SLPI is a better
inhibitor than PI when used at the same concen-
tration but separate from each other. SLPI and PI
were never used in combination, as is known to
occur in vivo . Although it is likely that in the
absence of sufcient antiprotease protection, NE
also disrupts peripheral structural lung cell
integrity during emphysema, there are no quanti-
tative studies to illustrate this or to show how PI
and SLPI, alone or combined, inhibit the effects
of NEon peripheral lung cells.
Two important epithelial cells found in the
area affected by emphysema, the respiratory
bronchioles and alveolae, are the non-ciliated
bronchiolar secretory cell (NCBSC) and type II
pneumocyte respectively. Apart from producing
SLPI, the NCBSC produces other proteins, such
as surfactant apoproteins23 - 25 and Clara cell
secretory protein,26 while a major function of
the type II cell is to produce pulmonary
surfactant,27 the extracellular lining layer re-
sponsible for maintaining reduced surface ten-
sion and preventing alveolar collapse. Both cell
types are involved in the metabolism of
xenobiotics28,29 as well as acting as progenitors
to type I alveolar epithelial cells (type II30) and
ciliated cells (NCBSC31). Damage to these
epithelial cells could therefore have serious
consequences in terms of lung defence and
regeneration of damaged tissue. Adequate inhi-
bition of NE during inammatory cell inux to
the respiratory units would therefore be critical
in preventing the occurrence of emphysema
and in ammatory lung disease processes.32
It is not possible to investigate the exact
relationship between changes in NE load, inhibi-
tor pro le and lung tissue damage that may be
relevant to the development of emphysema in an
in vivo model. Consequently, we have adapted a
model that was previously used to assess
bronchiolar33 and alveolar34 toxicity in vitro , to
study the effect of NE on respiratory epithelial
cells under dened experimental conditions. The
speci c aim was to determine the effect of NEon
pulmonary epithelial type II and NCBSC cell
detachment from (i.e. damage), and their ability
to adhere to (i.e. repair), extracellular matrix in
vitro . The use of matrix was regarded as crucial
as, in vivo , these cells would either be in contact
with, or re-populate, extracellular matrix of
either epithelial or endothelial origin. Therefore,
matrices generated by both epithelial and en-
dothelial cells were examined. As our previous
studies on human bronchoalveolar lavage
showed that the ratio of PI to SLPI varied,13 the
protective effect of PI and SLPI on NE-induced
damage was also investigated when used alone
andwhen combined in ratios representing that in
normal bronchoalveolar lavage (PI:SLPI 9:113)
and bronchoalveolar lavage from smokers with
obstructive lung disease (PI:SLPI1:113).
Methods
Activity of NE and antiproteases
The relative activity of commercially obtained
NE (Elastin Products Comp. Inc., MO, USA) was
assayed using the method of Nakajima et al.35
The activity of PI (Sigma, A9024) and SLPI
(puri ed in this laboratory as described pre-
viously14) was assessed against this NE and the
molar concentration of active inhibitor could
then be determined on the basis that PI and
SLPI inhibit NE on a 1:1 molar basis.
These assays were carried out immediately
before each experiment and inhibitory capacity
was also assessed after incubation under experi-
mental conditions at 378 C (without cells) for
18 h.
Animals and removal of lungs for
epithelial cell preparation
Male mice (BALB/C 25±30 g) and rats (WAG
250±300 g), bred in-house, were killed by a
lethal intra-peritoneal injection of phenobarbi-
tone/0.15 M saline (1:1 v/ v) containing
300 units/ml heparin. The lungs were perfused
free of blood by gravity feed of 0.15 MNaCl via
the pulmonary artery and carefully removed
intact from the cavity with a tracheal cannula
still tied in place. The excised lungs were
lavaged to remove free alveolar cells and
pulmonary airway secretions (4 3 0·6 ml [mice]
and 4 3 10 ml [rats] of sterile 0.15MNaCl).
Isolation of mouse NCBSC
NCBSC were isolated using the method of
Oreffo et al.36 The nal cell sample was
suspended in DCCM-1 medium (Biological In-
dustries, Glasgow) containing 0.4% Ultroser G
(Gibco, Paisley) and plated according to the
protocol described below.
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Isolation of rat type II cells
Type II cells were isolated using the method of
Richards et al.37 The nal cell pellet was
processed in the same way as the NCBSC.
Identi® cation of NCBSC
Functional NCBSC may be distinguished from
other cells present in the preparation by their
high levels of nitroblue tetrazolium (NBT) re-
ductase. The method of Oreffo et al.36 was used
to estimate the proportion of NCBSC present in
the original isolate as well as those remaining
after treatment with enzyme and inhibitors.
Identi® cation of type II cells
The type II cell is the only cell in the lung with
appreciable levels of the enzyme alkaline phos-
phatase, this was therefore used to identify type
II cells in the original cell isolate following the
method of Miller et al.38
To estimate the number of cells remaining
after enzyme/inhibitor treatment the cells were
stained with Giemsa which has the advantage
over the alkaline phosphatase stain which does
not involve xation and cannot be stored for
long periods of time to enable counting.
Experimental protocol
The experimental model was a modication of
those described previously for toxicological
studies on pulmonary alveolar and bronchiolar
epithelial cells in vitro .33,34 To mimic the in
vivo conditions of adherence to extracellular
matrix of endothelial origin, 96 well plates, in
which endothelial cells were previously grown
under controlled conditions, were used (Bio-
logical Industries). The cells are removed prior
to purchase, leaving a coat of endothelial cell-
derived extracellular matrix. This matrix is
referred to as endothelial matrix in this study. It
is similar in its composition to naturally occur-
ring endothelial cell basement membrane which
contains type IV collagen, laminin, heparan
sulphate proteoglycan, bronectin, entactin and
nidogen. To mimic the in vivo situation of
adherence to epithelial matrix, untreated 96
well plates were coated with Matrigel (Gibco,
Paisley), an extracellular matrix of basement
membrane synthesized by Engelbreth-Holm-
Swarm mouse sarcoma consisting of laminin,
type IV collagen, heparan sulphate proteogly-
can, entactin and nidogen. This matrix is
referred to as epithelial matrix in this study.
Cells were plated onto 96 well plates,
5 3 104 cells/ 100 ml DCCM-1 + 0.4% Ultroser
G (media)/well, which were coated with either
endothelial or epithelial matrix. Cells were stud-
ied either prior to adherence or following
adherence, as follows:
(a) adherent cells , allowed to adhere for 16 h,
the media removed, 100 ml of fresh media
added to each well and exposed to NE and
inhibitors for 2 h;
(b) freshly plated cells , treated with enzyme
and inhibitors at the time of plating and
incubated for 18 h.
Effect of NE and inhibitors on cell
adherence/detachment
Fifty ml of media containing 0, 2, 10, 20 and
40 pmol active inhibitor in each of the follow-
ing combinations—PI alone, SLPI alone, 9 PI:1
SLPI and 1 PI:1 SLPI—were then added. Imme-
diately after, 50 ml of media containing 0, 3, 6,
12 and 24 pmol active NE were added to each
dose and each combination of inhibitor. Thus
cells were incubated (i) alone, (ii) with all doses
of NE, and (iii) with each dose of NE mixed
with every dose and combination of inhibitor.
After 2 (adherent cells) or 18 h (freshly plated
cells; see above), the incubation media and any
non-adherent or dislodged cells were removed.
Non-adherent cells were assayed for viability
with trypan blue, while adherent cells were
stained and counted as described above. This
experiment was performed in triplicate for each
set of conditions on three separate occasions.
Enumeration of cells
After staining, a representative tract of the
culture was selected across the diameter of the
well to account for any plating anomalies. Three
different areas were counted along this tract
(for control cultures this represents 800±1000
cells) and from this the mean number of
cells/ unit area could be ascertained. Within any
one well the standard error of the mean, in
control cultures, or those treated with the same
dose of HNE (where applicable) did not exceed
15%. The number of cells/ unit area deter-
mined for the control culture was taken as
100% and the number of attached cells/ unit
area in the presence of elastase and/or inhibi-
tors was expressed as a percentage of the
control value.
All data obtained from these experiments
were analysed using analysis of variance (BMDP
Statistical Software, University of California).
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Release by NE of endothelial and
epithelial matrix from tissue culture
plastic
Matrix that is not populated by adherent cells
may be susceptible to NE (e.g. in studies of
non-adherent cells) and is likely to be degraded/
modied and contribute to changes in epithelial
cell adherence. Inhibitors may modify the effect
of NE on the matrix. Thus, both endothelial and
epithelial matrix-coated plates were exposed to
NE and inhibitors in an identical manner to that
described above for non-adherent cells but in
the absence of cells, to examine the effect of
NE on the matrix alone. After 18 h, the medium
was removed, the wells washed in PBS buffer
and the remaining matrix protein level assayed
in situ using the Bicinchoninic acid (BCA)
protein assay as described in the manufacturer’s
instruction manual (Pierce, Rockford, Illinois,
USA). Absorbance was measured at 562 nm on
a Labsystems MCC340 plate reader and protein
levels expressed as a percentage of the non-
proteolysed control value.
Results
Cell isolation
The proportion of type II cells present in the
original isolate was 95±99%whilst the propor-
tion of NCBSC was 70±75%. Fig. 1 shows
representative cultures, growing on endothelial
matrix (type II, Fig. 1A; NCBSC, Fig. 1D).
Effect of NE on ECM and matrigel
Elastase caused the release of endothelial matrix
from tissue culture plastic in a dose-dependent
manner; even 3 pmol of enzyme caused 35%
degradation whilst 12 and 24 pmol caused over
80%degradation (Fig. 2). There was no release
of epithelial matrix (data not shown).
Effect of PI and SLPI on NE-induced
endothelial matrix degradation
There was no loss of NE activity or inhibitory
capacity of PI or SLPI incubated in tissue culture
media for 18 h (data not shown). When en-
dothelial matrix was incubated with low doses
of NE, 10 pmol or more of PI or SLPI performed
similarly and prevented, or signicantly re-
duced, endothelial matrix degradation (Fig. 2).
However, the effect of higher doses of NE could
not be completely prevented by the addition of
a molar excess of PI or SLPI, although SLPI was
more effective.
NE-induced detachment of adherent
cells
Three pmol of NE did not induce epithelial cell
detachment and no further studies were carried
out with this dose of enzyme (data not shown).
Although 6 pmol NE did not affect NCBSC or
cause type II cell detachment from endothelial
matrix, this dose of enzyme did cause type II
cell detachment from epithelial matrix (~ 40%
detachment, Fig. 3A). Furthermore, type II cells
were more susceptible than NCBSC to NE-
induced detachment from both matrices after
exposure to 12 pmol NE (P , 0·001). Twenty-
four pmol NE had a similar effect on both cell
types causing 70±80% detachment from both
matrices.
Thus, unlike type II cells, detachment of
NCBSC was not differentially affected by the
matrix to which they adhered but was related
to dose (Fig. 3A). This effect of NE is illustrated
in Fig. 1.
Effect of NE on cell adherence of
freshly plated cells
The effect of NE on the adhesion of freshly
plated cells is shown in Fig. 3B. Since the initial
study with adherent cells showed that 6 pmol
NE had little effect, the effect of this dose of
enzyme was not examined.
The adherence of freshly plated type II cells
on to endothelial matrix was reduced to 33%
and 7%of untreated cells when exposed to 12
and 24 pmol NE respectively, while the adher-
ence of NCBSC was virtually abolished (Fig.
3B). The effect of 12 pmol NE on type II cell
adherence to epithelial matrix was similar to
that seen on endothelial matrix (28% of con-
trol). However, NCBSC adherence to epithelial
matrix was less affected (Fig. 3B). The effect of
24 pmol NE on the adherence of both cell types
to epithelial matrix was similar (~ 12% of
control).
Differential effect of NE on freshly
plated compared with adherent
epithelial cells
The effects of 24 pmol NE on adherence of
freshly plated cells was more marked than that
on cell detachment; thus in every equivalent
combination of cell type, matrix and dose of
enzyme, proportionally more freshly plated cells
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FIG. 1. Adherent alveolar type II cells (A±C) and NCBSC (D±F). Before treatment (A, D); after treatment with 24 pmol NE
(B, E); after concurrent treatment with 24 pmol NE and 20 pmol PI (C, F).
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were prevented from adhering than were dis-
placed by NE (Fig. 3).
Prevention of NE-induced changes in
cell adherence by PI and SLPI
Two pmol of inhibitor had a negligible effect on
NE-induced cell attachment or detachment. The
effect of 6 pmol of NE was efciently prevented
by all levels and combinations of inhibitors
(data not shown). The effect of inhibitors on 12
and 24 pmol NE were similar, and related to the
ratio of enzyme to inhibitor. Consequently the
data for 24 pmol NE is presented as this allows
discussion of a wider range of inhibitor to
enzyme ratios. The protective effects of inhibi-
tor are illustrated pictorially in Fig. 1.
Prevention of NE-induced cell
detachment by PI and SLPI
Endotheli al m atrix. Forty pmol of any combina-
tion of inhibitor prevented the effects of
24 pmol NE on type II cell detachment. Addi-
FIG. 2. The effect of incubation of endothelial matrix-coated wells with NE. The solid line represents the proteolytic effect of
NE alone, while the bars represent NE in the presence of SLPI or PI.
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tion of approximately equimolar concentrations
of inhibitor (i.e. 24 pmol NE: 20 pmol inhibitor)
partially prevented NE-induced type II cell
detachment. This effect was positively related
to the level of SLPI, SLPI being approximately
1.5 times as effective as PI alone (Fig. 4A). A
small but signicant effect on NE-induced type
II cell detachment was seen with 10 pmol
inhibitor.
In contrast, there was no difference between
PI and SLPI in their ability to prevent NE-
induced NCBSC detachment from endothelial
matrix. The reduction in cell detachment in the
presence of inhibitor was directly related to
inhibitor level, such that with 10 pmol of
inhibitor only 50% (compared with 20%) were
dislodged, while there was no cell detachment
with 40 pmol of inhibitor (Fig. 4B).
Epitheli al m atrix. Forty pmol of any combina-
tion of inhibitor prevented NE-induced cell
detachment of both type II and NCBSC cells.
The action of 24 pmol NE on both cell types
could be inhibited by 20 pmol of inhibitor,
inhibition being more effective with increasing
SLPI to PI ratio (SLPI 1.5±2 times more effective
than PI, Fig. 4C,D). Interestingly a similar
inhibitory pattern was observed when NCBSC
cells were exposed to 24 pmol NE and 10 pmol
inhibitor.
Prevention of the effects of NE on
epithelial cell adherence by PI and
SLPI
Endotheli al m atrix. The effects of 24 pmol NE
on either cell type could not be completely
prevented by 20 or 40 pmol of either inhibitor
despite their ability to inhibit NE on a 1:1 molar
basis in the absence of cells (Fig. 5A). Forty pmol
PI signicantly prevented the effects on type II
cell adherence, allowing adherence to increase
from 7%to 50%of the unexposed control level.
However, 40 pmol SLPI was more effective,
causing a reversal that achieved adherence that
was 89%of unexposed control levels (Fig. 5A). A
similar but less effective pattern on NEinhibition
was observed with NCBSC exposed to 24 pmol
NE. Thus, although there was no improvement
in adherence of NCBSCafter addition of 40 pmol
PI, 40 pmol SLPI allowed 51% of the control
adherence level. Inhibition was nevertheless
FIG. 4. Comparison between the inhibitory effect of PI and SLPI on 24 pmol NE and the detachment of adherent cells from
endothelial matrix and epithelial matrix. The solid line represents NE alone while the bars represent NE in the presence of
inhibitor. = signi® cantly enhanced inhibition of the action of NE on type II cell adherence to endothelial matrix by SLPI
compared with PI; inhibitor level 20 pmol, P , 0.01; †= signi® cantly enhanced inhibition of the action of NE on epithelial cell
adherence to epithelial matrix by SLPI compared with PI; inhibitor level 20 pmol, P , 0.001; § = signi® cantly enhanced
inhibition of the action of NE on NCBSC adherence to epithelial matrix by SLPI compared with PI; inhibitor level 10 pmol,
P , 0.01.
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incomplete. For both cell types, the most effec-
tive reversal of the effect of NE occurred when
SLPI was present. This was most noticeable
when there were almost equimolar levels of NE
and inhibitor, the ef cacy of the inhibitor in-
creased with increasing levels of SLPI, SLPI being
two to 12 times more effective at preventing the
effects of NE than PI (Fig. 5A,B).
Epitheli al m atrix. In contrast to cell adherence
to endothelial matrix, the effect of 24 pmol of
NE on both cell types was almost completely
prevented by 40 pmol of any combination of
inhibitor whilst the lower doses of inhibitor
were also signicantly more effective at prevent-
ing the effects of 24 pmol NE in this situation
(Fig. 5). Once again at equimolar concentrations
of NE with inhibitor, SLPI was more effective
(approximately 1.5 times).
Discussion
Mediators released by neutrophils are thought
to make a signicant contribution to tissue
destruction; NE, in particular, has been shown
to play an important role in the initiation and
perpetuation of an inammatory response. Stud-
ies in experimental animals suggest that loosen-
ing of the respiratory epithelium may be an
early event in the development of emphy-
sema.39 We have shown that this could result
from release of excessive NE by neutrophils at
the apical pulmonary respiratory epithelium.
Although there have been numerous studies on
the effect of NE on airway epithelial cells7,40
little is known about its effect on the respira-
tory epithelium. In this study we examined the
effect of NE on adherent respiratory epithelial
cells (type II and NCBSC), representing resident
epithelial cells in situ, and non-adherent cells,
representing dislodged epithelial cells in s itu.
Dislodged or loosened cells may exist as a result
of previous protease action, oxidant action, due
to the cytotoxic effects of cigarette smoke, or
for other, unknown reasons.
As expected, when adherent cells were ex-
posed to NE, dose-dependent detachment of
both cell types was observed, although the
degree of detachment was greater with type II
cells than with NCBSC. In addition, the effect of
FIG. 5. Comparison between the inhibitory effect of PI and SLPI on 24 pmol NE and the ability of freshly plated cells to
adhere to endothelial matrix and epithelial matrix. The solid line represents NE alone while the bars represent NE in the
presence of inhibitor. = signi® cant prevention of the effect of NE on type II cell adherence to endothelial matrix by either PI
or SLPI; inhibitor levelÐ 40 pmol (P , 0.001), 20 pmol (P , 0.001, excepting PI alone), 10 pmol (P , 0.001, excepting PI alone)
and 2 pmol (P , 0.05, excepting PI alone); † = signi® cant prevention of the effect of NE on NCBSC adherence to endothelial
matrix by PI combined with SLPI; inhibitor level 40 pmol (P , 0.001), 20 pmol (P , 0.001) and 10 pmol (P , 0.05, SLPI alone);
§ = signi® cantly enhanced inhibition of the action of NE on epithelial cell adherence to endothelial matrix by SLPI compared
with PI; inhibitor level 20 pmol, P , 0.001; ‡= signi® cantly enhanced inhibition of the action of NE on epithelial cell
adherence to epithelial matrix by SLPI alone compared with PI alone: inhibitor level 20 pmol, P , 0.05.
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NE on adherent NCBSCwas independent of the
source of the extracellular matrix, whereas type
II cells were more susceptible to NE-induced
detachment from epithelial matrix than from
endothelial matrix. This suggests that, in situ,
NCBSC are less likely to be displaced by NE
than alveolar type II cells, which are most
vulnerable when in contact with epithelial cell-
derived matrix.
In contrast, the effect of NE on cell adherence
of freshly plated cells was more marked and
suggests that alveolar type II cells would be
more likely than NCBSC to ‘re-populate’ de-
nuded, exposed matrix. Since NE degrades
endothelial matrix (possibly re ecting degrada-
tion of the bronectin component) and NCBSC
do not adhere to tissue culture plastic, it seems
possible that susceptibility of extracellular ma-
trix to NE and preference of NCBSC for a
speci c matrix may exist in vivo and hence be
important in repopulation and repair mechan-
isms. Furthermore, NE may be acting on cell
membrane proteins, such as adhesion mole-
cules, since both type II cell and NCBSC
adherence to epithelial matrix was inhibited by
NE, even though the epithelial matrix used in
this study was not signi cantly solubilized by
NE under these experimental conditions.
Protection, by SLPI, of epithelial cells from
NE-induced damage, was equal to, or better
than, the serum-derived inhibitor, PI, and was
most noticeable when the enzyme:inhibitor
ratios were almost equivalent, a situation that
might occur in the microenvironment of the
phagocyte in vivo . Indeed, PI was often a poor
inhibitor of the effects of NE, particularly on
adherence of freshly plated cells to endothelial
matrix. This probably reects two factors—
endothelial matrix is proteolysed by NE and PI
cannot inhibit NE bound to extracellular
matrix.10,32 Thus, prior to cell adherence, NE
probably bound rapidly to endothelial matrix
and, having done so, could only be inhibited by
SLPI (SLPI is believed to bind to extracellular
matrix and can inhibit extracellular matrix-
bound NE).10,41 This explanation is supported
by the observation that, when studied in the
absence of cells, more endothelial matrix was
found to be solubilized by NE in the presence
of PI than SLPI. Such complex interactions may
explain why a molar excess of inhibitor would
not always prevent NE-induced epithelial cell
damage. Reduced levels or activity of SLPI in
vivo (which is released both apically and
basally, into the interstitial extracellular matrix,
by secretory epithelial cells42) might mean that
NE that has bound to extracellular matrix
cannot be sufciently inhibited by other inhibi-
tors present within the lung tissue and hence
that tissue proteolysis will progress. This is
supported by a recent study43 which showed a
negative correlation between elevated NE activ-
ity and SLPI levels in sputum from patients who
had exacerbative chronic obstructive pulmon-
ary disease, suggesting that the condition was
worse when SLPI levels were reduced. There
was no correlation between PI levels, NE
activity and respiratory symptoms, possibly
highlighting the signicance of SLPI in control-
ling the action of NE and severity of disease.
It is interesting that adherent NCBSC were
markedly more resistant to NE than non-adher-
ent NCBSC and also that the difference between
the protective effects of PI and SLPI were less
noticeable following epithelial cell adherence.
As the cells had already adhered, less extracel-
lular matrix or cell surface molecules would be
exposed to NE and hence less ‘protection’
would be required from the inhibitors. PI would
be more likely to inhibit unbound NE, having a
higher Kass than SLPI for free NE.11,44 Synthesis
and secretion of SLPI by the adherent NCBSC
may also provide increased protection from NE,
although analysis of NCBSC culture supernatant
with antibodies to human SLPI was negative
(data not shown). However, this may re ect
lack of cross-reactivity between species.
The data suggest that even when the propor-
tion of SLPI in the antiprotease mixture added
to the cells is only 10%of the total (cf. normal
lung ratios13,15), the degree of protection from
NE-induced damage is increased above that of
PI alone. Since those with bronchitis and em-
physema may have even higher proportions of
SLPI (50%13) and in the present study a 1:1 ratio
of PI to SLPI conferred greater protection from
NE-induced damage, one could hypothesize that
increased production of SLPI by the pulmonary
epithelium gives extra protection and may be a
defence mechanism rather than a non-speci c
result of hypersecretion.
In conclusion, this study suggests that incom-
plete inhibition of NE released at the apical
surface of respiratory epithelium may contri-
bute to loosening and possibly detachment of
the epithelium. The magnitude of the effect is
likely to depend on both the nature of the
underlying matrix (i.e. susceptibility to NE) and
the differential action of the enzyme on epithe-
lial cells from bronchiolar and alveolar regions
of the respiratory unit, including adhesion
molecules. Weak epithelial cell adhesion and
cell detachment is likely to facilitate access of
enzyme to the underlying interstitium and extra-
cellular matrix, including basement membrane
and elastic tissue, which are susceptible to
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proteolysis by NE. Such mechanisms may con-
tribute to the tissue damage that occurs during
the development of emphysema. Finally, this
study shows that SLPI, particularly in combina-
tion with PI, plays a major role in protecting
lung cells and interstitial components from the
destructive action of NE. We hypothesize that
reduced levels or activity of SLPI in vivo may
contribute to NE-induced lung damage and
neutrophil-mediated lung disease.
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